Role of GSK-3β in Regulation of Canonical Wnt/β-catenin Signaling and PI3-K/Akt Oncogenic Pathway in Colon Cancer

被引:54
|
作者
Jain, Shelly [1 ]
Ghanghas, Preety [1 ]
Rana, Chandan [1 ]
Sanyal, S. N. [1 ]
机构
[1] Panjab Univ, Dept Biophys, Chandigarh 160014, India
关键词
Akt; beta-catenin; colorectal cancer; DMH; GSK-3; beta; PI3-K; NITRIC-OXIDE SYNTHASE; ABERRANT CRYPT FOCI; BETA-CATENIN; PHOSPHATIDYLINOSITOL; 3-KINASE/AKT; CYCLOOXYGENASE-2; INHIBITOR; COLORECTAL-CANCER; DOWN-REGULATION; APOPTOSIS; CELECOXIB; DICLOFENAC;
D O I
10.1080/07357907.2017.1337783
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
Non-steroidal anti-inflammatory drugs (NSAIDs) are emerging as novel chemopreventive agents because of their ability in blocking cellular proliferation, and thereby tumor development, and also by promoting apoptosis. GSK-3 beta, a serine threonine kinase and a negative regulator of the oncogenic Wnt/beta-catenin signaling pathway, plays a critical role in the regulation of oncogenesis. Celecoxib and etoricoxib, the two cyclooxygenase-2 (COX-2) selective NSAIDs, and Diclofenac, a preferential COX-2 inhibitory NSAID, had shown uniformly the chemopreventive and anti-neoplastic effects in the early stage of colon cancer by promoting apoptosis as well as an over-expression of GSK-3 beta while down-regulating the PI3-K/Akt oncogenic pathway.
引用
收藏
页码:473 / 483
页数:11
相关论文
共 50 条
  • [21] Selenium Enhances the Growth of Bovine Endometrial Stromal Cells by PI3K/AKT/GSK-3β and Wnt/β-Catenin Pathways
    Dong, Junsheng
    Wang, Zi
    Fei, Fan
    Jiang, Yeqi
    Jiang, Yongshuai
    Guo, Long
    Liu, Kangjun
    Cui, Luying
    Meng, Xia
    Li, Jianji
    Wang, Heng
    VETERINARY SCIENCES, 2024, 11 (12)
  • [22] ADORA1 promotes nasopharyngeal carcinoma cell progression through regulation of PI3K/AKT/GSK-3β/β-catenin signaling
    Pan, Suming
    Liang, Sixian
    Wang, Xianyan
    LIFE SCIENCES, 2021, 278
  • [23] Luteolin Induces Growth Arrest in Colon Cancer Cells Through Involvement of Wnt/β-Catenin/GSK-3β Signaling
    Pandurangan, Ashok Kumar
    Dharmalingam, Prakash
    Sadagopan, Suresh Kumar Ananda
    Ramar, Manikandan
    Munusamy, Arumugam
    Ganapasam, Sudhandiran
    JOURNAL OF ENVIRONMENTAL PATHOLOGY TOXICOLOGY AND ONCOLOGY, 2013, 32 (02) : 131 - 139
  • [24] Celastrol inhibits colon cancer cell proliferation by downregulating miR-21 and PI3K/AKT/GSK-3β pathway
    Ni, Haoliang
    Han, Yuejun
    Jin, Xihan
    INTERNATIONAL JOURNAL OF CLINICAL AND EXPERIMENTAL PATHOLOGY, 2019, 12 (03): : 808 - 816
  • [25] miRNA-29a inhibits colon cancer growth by regulation of the PTEN/Akt/GSK3β and Wnt/β-catenin signaling pathways
    Han, Xiaofeng
    Zheng, Jianwei
    Wang, Yunlei
    Gao, Zhigang
    ONCOLOGY LETTERS, 2018, 16 (02) : 2638 - 2644
  • [26] Possible Involvement of PI3-K/Akt-Dependent GSK-3β Signaling in Proliferation of Neural Progenitor Cells After Hypoxic Exposure
    Keishi Kisoh
    Hideki Hayashi
    Miho Arai
    Maiko Orita
    Bo Yuan
    Norio Takagi
    Molecular Neurobiology, 2019, 56 : 1946 - 1956
  • [27] Mechanical Stress Regulates Osteogenesis and Adipogenesis of Rat Mesenchymal Stem Cells through PI3K/Akt/GSK-3β/β-Catenin Signaling Pathway
    Song, Fanglong
    Jiang, Dawei
    Wang, Tianchen
    Wang, Yi
    Lou, Yi
    Zhang, Yinquan
    Ma, Hui
    Kang, Yifan
    BIOMED RESEARCH INTERNATIONAL, 2017, 2017
  • [28] Possible Involvement of PI3-K/Akt-Dependent GSK-3 Signaling in Proliferation of Neural Progenitor Cells After Hypoxic Exposure
    Kisoh, Keishi
    Hayashi, Hideki
    Arai, Miho
    Orita, Maiko
    Yuan, Bo
    Takagi, Norio
    MOLECULAR NEUROBIOLOGY, 2019, 56 (03) : 1946 - 1956
  • [29] Nuclear GSK-3β inhibits the canonical Wnt signalling pathway in a β-catenin phosphorylation-independent manner
    M Caspi
    A Zilberberg
    H Eldar-Finkelman
    R Rosin-Arbesfeld
    Oncogene, 2008, 27 : 3546 - 3555
  • [30] Nuclear GSK-3β inhibits the canonical Wnt signalling pathway in a β-catenin phosphorylation-independent manner
    Caspi, M.
    Zilberberg, A.
    Eldar-Finkelman, H.
    Rosin-Arbesfeld, R.
    ONCOGENE, 2008, 27 (25) : 3546 - 3555